Condition: Diabetic Retinopathy · Diabetes Mellitus, Type 2 · Diabetic Complication · Sponsor: Association for Innovation and Biomedical Research on Light and Image
The purpose of this clinical study is to explore imaging, functional and systemic biomarkers of diabetic retinopathy (DR) progression, in Type 2 Diabetes (T2D) patients with moderate to severe non-proliferative diabetic retinopathy (NPDR) and mild proliferative diabetic retinopathy (PDR) using state of the art methodologies, commonly applied in clinical practice, over a period of two years. This study will provide longitudinal data to better understand retinal changes in moderate to severe diabetic retinopathy and early proliferative diabetic retinopathy and help guide timely interventions to prevent vision loss.
This description comes directly from the study's public registry record.
Joana Tavares, PhD · +351239480137 · jftavares@aibli.pt
Liliana C Soares, MsC · +351239480105/131 · important_4c@aibili.pt
Always discuss trial participation with your own doctor first.
| AIBILI-CEC (AIBILI-Clinical Trial Centre) | Coimbra, Portugal | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07458516